T cells in psoriatic arthritis

被引:16
作者
Choy E. [1 ]
机构
[1] Academic Department of Rheumatology, King's College London, Weston Education Center, London, SE5 9PJ, Cutcombe Road
关键词
Psoriasis; Ectopic Lymphoid Neogenesis; Heral Blood;
D O I
10.1007/s11926-007-0071-5
中图分类号
学科分类号
摘要
Psoriatic arthritis is characterized by chronic inflammation of the skin and synovial joint. T cells are abundant in the inflamed joint and skin. Disease susceptibility is associated with major histocompatibility complex, which presents antigens to T cells. T cells in the synovial joints have an activated phenotype and demonstrate selective T-cell receptor usage suggestive of oligoclonal expansions. Taken together, these facts suggest that psoriatic arthritis is driven by antigen or autoantigen-driven T-cell activation. The therapeutic benefit of anti-T-cell agents further supports an important pathogenic role for T cells in persistent synovial inflammation and joint damage in psoriatic arthritis. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:437 / 441
页数:4
相关论文
共 35 条
[1]  
Wright V., Moll J.M., Psoriatic arthritis, Bull Rheum Dis, 21, pp. 627-632, (1971)
[2]  
Taylor W., Gladman D., Helliwell P., Et al., Classification criteria for psoriatic arthritis: Development of a new criteria from a large international study, Arthritis Rheum, 54, pp. 2665-2673, (2006)
[3]  
Husted J.A., Tom B.D., Farewell V.T., Et al., A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?, Arthritis Rheum, 56, pp. 840-849, (2007)
[4]  
Bond S.J., Farewell V.T., Schentag C.T., Gladman D.D., Predictors for radiological damage in psoriatic arthritis: Results from a single center, Ann Rheum Dis, 66, pp. 370-376, (2007)
[5]  
Rahman P., Elder J.T., Genetic epidemiology of psoriasis and psoriatic arthritis, Ann Rheum Dis, 64, pp. 37-39, (2005)
[6]  
Baker B.S., Swain A.F., Valdimarsson H., Fry L., T-cell subpopulations in the blood and skin of patients with psoriasis, Br J Dermatol, 110, pp. 37-44, (1984)
[7]  
Petzelbauer P., Pober J.S., Keh A., Braverman I.M., Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients, J Invest Dermatol, 103, pp. 300-305, (1994)
[8]  
Oxholm A., Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans, APMIS Suppl, 24, pp. 1-32, (1992)
[9]  
Davison S.C., Ballsdon A., Allen M.H., Barker J.N., Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques, Exp Dermatol, 10, pp. 280-285, (2001)
[10]  
Pitzalis C., Cauli A., Pipitone N., Et al., Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis, Arthritis Rheum, 39, pp. 137-145, (1996)